scholarly journals Oral Zinc Supplementation Decreases the Serum Iron Concentration in Healthy Schoolchildren: A Pilot Study

Nutrients ◽  
2014 ◽  
Vol 6 (9) ◽  
pp. 3460-3473 ◽  
Author(s):  
Naira de Brito ◽  
Érika Rocha ◽  
Alfredo de Araújo Silva ◽  
João Costa ◽  
Mardone França ◽  
...  
Keyword(s):  
Pilot Study ◽  
Serum Iron ◽  
Zinc Supplementation ◽  
Iron Concentration ◽  
Serum Iron Concentration

Effect of Phenylhydrazine and Bone Marrow Inhibitors on Red Cell Destruction and Serum Iron Concentration

1958 ◽  
Vol 193 (1) ◽  
pp. 92-94
Author(s):  
Alfred Chanutin
Keyword(s):  
Bone Marrow ◽  
Serum Iron ◽  
Iron Concentration ◽  
Hemoglobin Concentration ◽  
Moderate Increase ◽  
Serum Iron Concentration ◽  
Moderate Anemia ◽  
Sublethal Doses ◽  
Slight Depression ◽  
Marrow Activity

The administration of sublethal doses of bone marrow depressants (nitrogen mustard, triethylene melamine and thioguanine) causes a temporary, moderate increase in serum iron concentration, a slight depression of bone marrow activity and no change in hemoglobin concentration. A combination of any of these drugs with a small dose of phenylhydrazine causes a temporary marked hyperferremia, a moderate anemia and a marked reticulocytosis. The results indicate that hyperferremia is not necessarily associated with bone marrow activity.

Iron Absorption after Single Pharmacological Oral Iron Loading Test in Patients on Chronic Peritoneal Dialysis and in Healthy Volunteers

2000 ◽  
Vol 20 (6) ◽  
pp. 662-666 ◽  
Author(s):  
Bahar Bastani ◽  
Shah Islam ◽  
Nasser Boroujerdi
Keyword(s):  
Serum Iron ◽  
Iron Absorption ◽  
Iron Concentration ◽  
Significant Rise ◽  
Oral Iron ◽  
Iron Sulfate ◽  
Chronic Peritoneal Dialysis ◽  
Dialysis Patients ◽  
Control Subjects ◽  
Serum Iron Concentration

Objective Oral iron is poorly absorbed in chronic dialysis patients. We tested the hypothesis that a superpharmacologic dose of iron sulfate (260 mg elemental iron) administered on an empty stomach results in significant iron absorption in these patients. Design A prospective open controlled trial. Setting Outpatient department of a university hospital. Patients Nine stable chronic peritoneal dialysis (PD) patients and seven normal control subjects. Method All subjects ingested a single dose of 4 tablets of iron sulfate (260 mg elemental iron total) in the morning while fasting. Outcome Measures Serum iron concentrations at baseline, and at 2 and 4 hours after the oral dose were compared between the two groups. Results The control group showed a significant rise in mean [± standard error (SE)] serum iron concentration, from a baseline value of 76.5 ± 7 μg/dL to 191 ± 10.5 μg/dL at 2 hours and to 190 ± 24 μg/dL at 4 hours. This result represents a percentage rise of 164% ± 32% at 2 hours and 152% ± 28.5% at 4 hours. In the PD patients, a significant rise in serum iron concentration was also seen, from a baseline value of 64 ± 8 μg/dL to 130 ± 3 μg/dL at 2 hours and 111 ± 18 μg/dL at 4 hours. This result represents a percentage rise of 105% ± 29% at 2 hours and 77% ± 23.5% at 4 hours. However, the absolute change in serum iron concentration in PD patients at 2 and 4 hours was approximately equal to 50% of the change in control subjects at those time points. None of the PD patients experienced gastrointestinal side effects; 4 control subjects experienced mild side effects. Conclusion Despite impaired oral iron absorption in chronic dialysis patients, a large pharmacologic dose given orally can result in significant iron absorption and may prove to be a more efficient means of oral iron supplementation therapy in these patients.

Serum Iron Determinations

1958 ◽  
Vol 4 (4) ◽  
pp. 290-295 ◽  
Author(s):  
Harold L Rosenthal ◽  
Mari Lou Pfluke ◽  
Lois Jud
Keyword(s):  
Serum Iron ◽  
Iron Concentration ◽  
Serum Samples ◽  
Serum Iron Concentration ◽  
Control Serum ◽  
Control Samples

Abstract The inclusion of control serum samples for the estimation of serum iron by the Kingsley-Getchell bathophenanthroline and the Ramsay dipyridyl methods is necessary in order to correct for nonspecific absorption of serum pigments. In the absence of control samples, serum iron concentration may be from 25 to 90 per cent too high.

scholarly journals Use of iron sucrose injection in anemia patients with reduced serum iron concentration during hospitalizations of digestive and liver diseases

2020 ◽  
Vol 9 (5) ◽  
pp. 72-72
Author(s):  
Cen Hong ◽  
Xiangbo Xu ◽  
Ruirui Feng ◽  
Fernando Gomes Romeiro ◽  
Dan Zhang ◽  
...  
Keyword(s):  
Liver Diseases ◽  
Serum Iron ◽  
Iron Concentration ◽  
Iron Sucrose ◽  
Serum Iron Concentration

Serum iron concentration is associated with subcortical deep gray matter iron levels in multiple sclerosis patients

Neuroreport ◽  
2017 ◽  
Vol 28 (11) ◽  
pp. 645-648 ◽  
Author(s):  
Niels Bergsland ◽  
Simone Agostini ◽  
Maria M. Laganà ◽  
Roberta Mancuso ◽  
Laura Mendozzi ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Gray Matter ◽  
Serum Iron ◽  
Iron Concentration ◽  
Serum Iron Concentration ◽  
Deep Gray Matter ◽  
Multiple Sclerosis Patients

scholarly journals The effect of serum iron concentration on iron secretion into mouse milk

2000 ◽  
Vol 522 (3) ◽  
pp. 479-491 ◽  
Author(s):  
Peifang Zhang ◽  
Valerie Sawicki ◽  
Andy Lewis ◽  
Linda Hanson ◽  
Jenifer Monks ◽  
...  
Keyword(s):  
Serum Iron ◽  
Iron Concentration ◽  
Serum Iron Concentration ◽  
Mouse Milk
Sign in / Sign up

Export Citation Format

Share Document